This article is rated List-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||
|
Daily pageviews of this article
A graph should have been displayed here but
graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at
pageviews.wmcloud.org |
Hello, Wouldn't it be helpful to add the net profit of the companies to the list for the purpose of better comparison? If so, I could help to add these informations. Thanks for reading. — Preceding unsigned comment added by GentianB ( talk • contribs) 14:56, 26 March 2018 (UTC)
Why is Danaher on this list? They bought a tools company from GE, not a drug company. 98.184.199.149 ( talk) 15:15, 20 May 2019 (UTC)
References
Why is Abbott on this list - Abbott basically split off AbbVie long ago for the main part of its pharmaceutical business. Abbott's business now is like $4B in drug revenue with a ton of device and diagnostic stuff making up the bulk. This list isn't going to be very useful if it uses a company's overall revenue to determine position rather than the company's actual drug revenue. 98.184.199.149 ( talk) 14:39, 22 May 2019 (UTC)
Under the "Top pharmaceutical companies with revenue greater than $10 billion" section, the sort for the 2019 column is going by the first numbers, not the full numbers. For example, when set to sort in ascending order, the order of the numbers is: 2.79 (Labcorp); 20.2 (Johnson & and Johnson); 3.49 (Biogen). Johnson & Johnson, at 20.2, should come well further down the list after Biogen, which is at 3.49. As far as I could tell, this error only occurs with the 2019 column. Hope I made sense, thank you! JusInBello 19:53, 30 June 2019 (UTC)
Berojgari job 10th pass 2402:8100:2594:55D1:0:0:4CBA:76E1 ( talk) 21:28, 15 May 2024 (UTC)
This article is rated List-class on Wikipedia's
content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||
|
Daily pageviews of this article
A graph should have been displayed here but
graphs are temporarily disabled. Until they are enabled again, visit the interactive graph at
pageviews.wmcloud.org |
Hello, Wouldn't it be helpful to add the net profit of the companies to the list for the purpose of better comparison? If so, I could help to add these informations. Thanks for reading. — Preceding unsigned comment added by GentianB ( talk • contribs) 14:56, 26 March 2018 (UTC)
Why is Danaher on this list? They bought a tools company from GE, not a drug company. 98.184.199.149 ( talk) 15:15, 20 May 2019 (UTC)
References
Why is Abbott on this list - Abbott basically split off AbbVie long ago for the main part of its pharmaceutical business. Abbott's business now is like $4B in drug revenue with a ton of device and diagnostic stuff making up the bulk. This list isn't going to be very useful if it uses a company's overall revenue to determine position rather than the company's actual drug revenue. 98.184.199.149 ( talk) 14:39, 22 May 2019 (UTC)
Under the "Top pharmaceutical companies with revenue greater than $10 billion" section, the sort for the 2019 column is going by the first numbers, not the full numbers. For example, when set to sort in ascending order, the order of the numbers is: 2.79 (Labcorp); 20.2 (Johnson & and Johnson); 3.49 (Biogen). Johnson & Johnson, at 20.2, should come well further down the list after Biogen, which is at 3.49. As far as I could tell, this error only occurs with the 2019 column. Hope I made sense, thank you! JusInBello 19:53, 30 June 2019 (UTC)
Berojgari job 10th pass 2402:8100:2594:55D1:0:0:4CBA:76E1 ( talk) 21:28, 15 May 2024 (UTC)